Shephard Elizabeth A, Neal Richard D, Rose Peter, Walter Fiona M, Litt Emma J, Hamilton William T
University of Exeter Medical School, Exeter.
North Wales Centre for Primary Care Research, Bangor University, Wrexham.
Br J Gen Pract. 2015 Feb;65(631):e106-13. doi: 10.3399/bjgp15X683545.
Patients with myeloma experience the longest diagnostic delays compared with patients with other cancers in the UK; 37% are diagnosed through emergency presentations.
To identify and quantify the risk of myeloma from specific clinical features reported by primary care patients.
Matched case-control study using General Practice Research Database primary care electronic records.
Putative clinical features of myeloma were identified and analysed using conditional logistic regression. Positive predictive values (PPVs) were calculated for the consulting population.
A total of 2703 patients aged ≥40 years, diagnosed with myeloma between 2000 and 2009, and 12 157 age, sex, and general practice-matched controls were identified. Sixteen features were independently associated with myeloma: hypercalcaemia, odds ratio 11.4 (95% confidence interval [CI] = 7.1 to 18), cytopenia 5.4 (95% CI = 4.6 to 6.4), raised inflammatory markers 4.9 (95% CI = 4.2 to 5.8), fracture 3.1 (95% CI = 2.3 to 4.2), raised mean corpuscular volume 3.1 (95% CI = 2.4 to 4.1), weight loss 3.0 (95% CI = 2.0 to 4.5), nosebleeds 3.0 (95% CI = 1.9 to 4.7), rib pain 2.5 (95% CI = 1.5 to 4.4), back pain 2.2 (95% CI = 2.0 to 2.4), other bone pain 2.1 (95% CI = 1.4 to 3.1), raised creatinine 1.8 (95% CI = 1.5 to 2.2), chest pain 1.6 (95% CI = 1.4 to 1.8), joint pain 1.6 (95% CI = 1.2 to 2.2), nausea 1.5 (95% CI = 1.1 to 2.1), chest infection 1.4 (95% CI = 1.2 to 1.6), and shortness of breath 1.3 (95% CI = 1.1 to 1.5). Individual symptom PPVs were generally <1%, although were >10% for some symptoms when combined with leucopenia or hypercalcaemia.
Individual symptoms of myeloma in primary care are generally low risk, probably explaining diagnostic delays. Once simple primary care blood tests are taken, risk estimates change. Hypercalcaemia and leucopenia are particularly important abnormalities, and coupled with symptoms, strongly suggest myeloma.
在英国,与其他癌症患者相比,骨髓瘤患者的诊断延迟时间最长;37%的患者是通过急诊确诊的。
根据基层医疗患者报告的特定临床特征,识别并量化骨髓瘤风险。
利用全科医学研究数据库的基层医疗电子记录进行配对病例对照研究。
识别骨髓瘤的假定临床特征,并使用条件逻辑回归进行分析。计算咨询人群的阳性预测值(PPV)。
共识别出2703例年龄≥40岁、在2000年至2009年间被诊断为骨髓瘤的患者,以及12157例年龄、性别和全科医疗相匹配的对照者。16个特征与骨髓瘤独立相关:高钙血症,比值比11.4(95%置信区间[CI]=7.1至18);血细胞减少,5.4(95%CI=4.6至6.4);炎症标志物升高,4.9(95%CI=4.2至5.8);骨折,3.1(95%CI=2.3至4.2);平均红细胞体积升高,3.1(95%CI=2.4至4.1);体重减轻,3.0(95%CI=2.0至4.5);鼻出血,3.0(95%CI=1.9至4.7);肋骨疼痛,2.5(95%CI=1.5至4.4);背痛,2.2(95%CI=2.0至2.4);其他骨痛,2.1(95%CI=1.4至3.1);肌酐升高,1.8(95%CI=1.5至2.2);胸痛,1.6(95%CI=1.4至1.8);关节疼痛,1.6(95%CI=1.2至2.2);恶心,1.5(95%CI=1.1至2.1);胸部感染,1.4(95%CI=1.2至1.6);呼吸急促,1.3(95%CI=1.1至1.5)。个体症状的PPV一般<1%,不过某些症状与白细胞减少或高钙血症同时出现时,PPV>10%。
基层医疗中骨髓瘤的个体症状一般风险较低,这可能是诊断延迟的原因。一旦进行简单的基层医疗血液检测,风险估计就会改变。高钙血症和白细胞减少是特别重要的异常情况,与症状相结合,强烈提示骨髓瘤。